Co-Authors
This is a "connection" page, showing publications co-authored by SYED WAMIQUE YUSUF and CEZAR ILIESCU.
Connection Strength
2.498
-
Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the "forgotten pulmonic valve". Front Cardiovasc Med. 2022; 9:1071138.
Score: 0.221
-
Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med. 2022; 9:916325.
Score: 0.211
-
Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):275-290.
Score: 0.208
-
Rate of Progression of Aortic Stenosis in Patients With Cancer. Front Cardiovasc Med. 2021; 8:644264.
Score: 0.194
-
Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep. 2019 11 19; 21(11):140.
Score: 0.177
-
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
Score: 0.167
-
Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018 02 08; 20(2):10.
Score: 0.156
-
"Bringing on the light" in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry). Am Heart J. 2017 Dec; 194:83-91.
Score: 0.151
-
Carcinoid heart disease. Heart. 2017 10; 103(19):1488-1495.
Score: 0.149
-
Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients? J Am Coll Cardiol. 2016 09 06; 68(10):1143-4.
Score: 0.142
-
Radiation-related heart and vascular disease. Future Oncol. 2015; 11(14):2067-76.
Score: 0.126
-
Cardiac amyloidosis. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):265-77.
Score: 0.118
-
Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia. Tex Heart Inst J. 2010; 37(3):336-40.
Score: 0.089
-
Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. J Nucl Cardiol. 2024 Sep; 39:101909.
Score: 0.061
-
Elevated IL-6 and Tumor Necrosis Factor-a in Immune Checkpoint Inhibitor Myocarditis. Diseases. 2024 May 03; 12(5).
Score: 0.060
-
Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis. Front Cardiovasc Med. 2022; 9:1073804.
Score: 0.055
-
Myocardial Dysfunction in Patients with Cancer. Heart Fail Clin. 2022 Jul; 18(3):361-374.
Score: 0.053
-
Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. J Cardiovasc Imaging. 2019 Oct; 27(4):268-279.
Score: 0.044
-
Multimodality imaging in carcinoid heart disease. Open Heart. 2019; 6(1):e001060.
Score: 0.043
-
Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography. 2019 02; 36(2):229-236.
Score: 0.041
-
Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion. J Am Coll Cardiol. 2015 Sep 08; 66(10):1119-28.
Score: 0.033